Evidence map›Paper›PMID 37761256›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Next-Generation Sequencing-Based Analysis of Clinical and Pathological Features of

Jolanta Smok-Kalwat, Grzegorz Chmielewski, Rafał Stando, Jacek Sadowski, Paweł Macek, Artur Kowalik, Ewelina Nowak-Ozimek, Stanisław Góźdź

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jolanta Smok-KalwatDepartment of Clinical Oncology, Holycross Cancer Center, 25-734 Kielce, Poland.
Grzegorz ChmielewskiDepartment of Radiation Oncology, Holycross Cancer Center, 25-734 Kielce, Poland.ORCID 0000-0001-7835-523X
Rafał StandoDepartment of Radiation Oncology, Holycross Cancer Center, 25-734 Kielce, Poland.ORCID 0000-0002-2543-8370
Jacek SadowskiDepartment of Radiation Oncology, Holycross Cancer Center, 25-734 Kielce, Poland.
Paweł MacekDepartment of Oncology, Institute of Health Sciences, Collegium Medicum, Jan Kochanowski University, 25-516 Kielce, Poland.ORCID 0000-0001-9755-7507
Artur KowalikDepartment of Molecular Diagnostics, Holycross Cancer Centre, 25-734 Kielce, Poland.ORCID 0000-0002-3718-999X
Ewelina Nowak-OzimekDepartment of Molecular Diagnostics, Holycross Cancer Centre, 25-734 Kielce, Poland.
Stanisław GóźdźDepartment of Clinical Oncology, Holycross Cancer Center, 25-734 Kielce, Poland.
Holy Cross University · PLJan Kochanowski University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (

Indexed as

breast cancermolecular diagnosticsnext-generation sequencingoverall survivalPIK3CAprogression-free survival

Identifiers

PMID37761256
PMCPMC10528120
OpenAlexW4386607690

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.